Scott Holmes

Title: Scott Holmes - Innovator in Pharmaceutical Assays

Introduction

Scott Holmes is a notable inventor based in Middlebury, CT (US). He has made significant contributions to the field of pharmaceutical research through his innovative work. His expertise lies in developing assays that enhance the identification of compounds interacting with cellular proteins.

Latest Patents

Scott Holmes holds a patent for "Recombinant yeast cells for identifying receptor effectors." This invention provides a rapid and effective assay for screening and identifying pharmaceutically effective compounds that specifically interact with and modulate the activity of cellular proteins, such as receptors or ion channels. The assay enables the rapid screening of large numbers of compounds to identify those that act as agonists or antagonists to the bioactivity of the cellular protein. It is particularly useful for identifying surrogate ligands for receptors from small molecule or peptide libraries or peptides produced by an autocrine system.

Career Highlights

Scott is associated with Cadus Pharmaceutical Corp., where he applies his expertise in pharmaceutical development. His work has been instrumental in advancing the understanding of receptor interactions and their implications in drug discovery.

Collaborations

Some of his notable coworkers include Joshua Trueheart and Hans A Fuernkranz. Their collaborative efforts contribute to the innovative environment at Cadus Pharmaceutical Corp.

Conclusion

Scott Holmes is a distinguished inventor whose work in pharmaceutical assays has the potential to significantly impact drug discovery and development. His contributions continue to pave the way for advancements in the field.